Without RxMapper: Katie is a 43 year-old mother of three young children and breast cancer patient, who was preparing to begin a 5-year Tamoxifen regimen.
With RxMapper: Analysis of her DNA revealed that Katie has three distinct genes that indicate poor long term outcomes with the use of Tamoxifen. An RxMapper Network Pharmacist shared this evidence with Katie’s oncologist and recommended an alternative treatment of Anastrozole in combination with Lupron.
Improved Outcomes: This switch, based on her DNA, greatly improves the likelihood of a successful outcome in which her cancer remains in full remission.
Without RxMapper: Having suffered treatment failure with methotrexate, he would be prescribed HUMIRA at a cost of $6,300 a month, $75,600 per year, and would have to endure painful injections into his stomach twice a month.
With RxMapper: Matthew gets a one-on-one consult. Based on his DNA, an RxMapper Network Pharmacist recommends leflunomide, an oral medication that is easy to take and much more effective at treating Matthew’s arthritis; and it costs just $22 a month / $264 a year.
Improved Outcome: With RxMapper, Matthew feels better because he is able to effectively treat his arthritis and saves $75,300 each year.
Without RxMapper: Diagnosed with ulcerative colitis,Julie was prescribed HUMIRA at a cost of $6,300 a month, $75,600 per year, and would have to endure painful injections into her stomach twice a month. Unfortunately, she lacks the protein structure needed to metabolize the drug and her colitis worsened.
With RxMapper: Julie gets personalized medication advice. Based on her DNA, an RxMapper Network Pharmacist recommends azathioprine, an oral medication that is easy to take and much more effective at treating Julie’s ulcerative colitis; and it costs just $13.20 a month / $158.40 per year.
Improved Outcomes: With RxMapper, Julie feels better because she is able to effectively treat her colitis and saves $75,400 each year.
Without RxMapper: Jack’s cardiologist prescribes Clopidogrel and Warfarin as blood thinners. Jack survives the stent surgery but develops a major GI bleed from his medications. Jack is hospitalized for 13 days and requires three E.R. visits over the next 12 months. He misses over four weeks of work and his wife misses two weeks of work caring for him.
With RxMapper: Jack gets personalized medication advice from an RxMapper Network Pharmacist. Analysis of his DNA reveals that Warfarin is not an appropriate blood thinner for Jack, based on his genomics. The analysis also shows that he should respond well to Clopidogrel and Dabigatran.
Improved Outcomes: Jack is prescribed Clopidogrel and Dabigatran and recovers from his stent placement without complications or additional costs.